If you need more lookups,
subscriptions start at $34 USD/month.
Istvan Molnar Location
Boston, MA, US
Istvan Molnar Work
Chief Medical Officer @ (February 2023 - Present)
Owner and Manager @ KGIM Enterprises LLC (November 2021 - February 2023)
Chief Medical Officer @ (January 2020 - October 2021)
Chief Medical Officer @ (June 2017 - April 2019)
Vice President, Clinical Development @ (July 2014 - April 2017)
Director Clinical Development, Global Clinical Lead @ (September 2010 - June 2014)
Director Global Medical Affairs @ (March 2009 - September 2010)
Deputy Director, Global Medical Affairs @ (December 2007 - March 2009)
Fellow, then Assistant Professor @ (August 2000 - December 2007)
Staff physician @ Newport Medical Associates (August 1996 - May 2000)
Fellow @ (July 1995 - August 1996)
Medical Resident @ Meridia Huron Hospital (July 1992 - June 1995)
Istvan Molnar Education
Semmelweis University
Doctor of Medicine (M.D.)
1985-1991
Apáczai Csere János Gimnázium
High School
1981-1985
Istvan Molnar Skills
Oncology
Clinical Development
Medical Affairs
Hematology
Drug Development
Pharmaceutical Industry
Clinical Research
Clinical Trials
Internal Medicine
Infectious Diseases
Medical Writing
GCP
Pharmacovigilance
Therapeutic Areas
Market Access
Good Clinical Practice (GCP)
Leadership
Healthcare Management
Good Clinical Practice Gcp
PowerPoint
Management
Business Development
Microsoft Office
Good Clinical Practice
Istvan Molnar Summary
Istvan Molnar, based in Boston, MA, US, is currently a Chief Medical Officer at Radionetics Oncology. Istvan Molnar brings experience from previous roles at KGIM Enterprises LLC, Lantheus Medical Imaging, Fusion Pharmaceuticals and Merrimack Pharmaceuticals. Istvan Molnar holds a 1985 - 1991 Doctor of Medicine (M.D.) @ Semmelweis University. With a robust skill set that includes Oncology, Clinical Development, Medical Affairs, Hematology, Drug Development and more. Istvan Molnar has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Istvan Molnar?
Find contact details for 700 million professionals.